Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The transcription/DNA repair factor TFIIH consists of nine subunits, several exhibiting known functions: helicase/ATPase, kinase activity and DNA binding. Three subunits of TFIIH,
cdk7
, cyclin H and MAT1, form a ternary complex,
cdk-activating kinase
(
CAK
), found either on its own or as part of TFIIH. In the present work, we demonstrate that purified human
CAK
complex (free
CAK
) and recombinant
CAK
(rCAK) produced in insect cells exhibit a strong preference for the cyclin-dependent kinase 2 (cdk2) over a ctd oligopeptide substrate (which mimics the carboxy-terminal domain of the RNA polymerase II). In contrast, TFIIH preferentially phosphorylates the ctd as well as
TFIIE alpha
, but not cdk2. TFIIH was resolved into four subcomplexes: the kinase complex composed of
cdk7
, cyclin H and MAT1; the core TFIIH which contains XPB, p62, p52, p44 and p34; and two other subcomplexes in which XPD is found associated with either the kinase complex or with the core TFIIH. Using these fractions, we demonstrate that TFIIH lacking the
CAK
subcomplex completely recovers its transcriptional activity in the presence of free
CAK
. Furthermore, studies examining the interactions between TFIIH subunits provide evidence that
CAK
is integrated within TFIIH via XPB and XPD.
...
PMID:Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. 913 Jul 8